D. B. A. Hutchinson P. J. A. Hutchinson

Object. Clinical microdialysis enables monitoring of the cerebral extracellular chemistry of neurosurgical patients. Introduction of the technique into different hospitals' neurosurgical units has resulted in variations in the method of application. There are several variables to be considered, including length of the catheter membrane, type of perfusion fluid, flow rate of perfusion fluid, and on-line compared with delayed analysis of samples. The objects of this study were as follows: 1) to determine the effects of varying catheter characteristics on substance concentration; 2) to determine the relative recovery and true extracellular concentration by varying the flow rate and extrapolating to zero flow; and 3) to compare substance concentration obtained using a bedside enzyme analyzer with that of off-line high-performance liquid chromatography (HPLC).Methods. A specially designed bolt was used to conduct two adjacent microdialysis catheters into the frontal cortex of patients with head injury or poor-grade subarachnoid hemorrhage who were receiving ventilation. One reference catheter (10-mm membrane, perfused with Ringer's solution at 0.3 µl/minute) was constant for all studies. The other catheter was varied in terms of membrane length (10 mm or 30 mm), perfusion fluid (Ringer's solution or normal saline), and flow rate (0.1–1.5 µl/minute). The effect of freezing the samples on substance concentration was established by on-line analysis and then repeated analysis after storage at −70°C for 3 months. Samples assayed with the bedside enzyme analyzer were reassessed using HPLC for the determination of glutamate concentrations.Conclusions. Two adjacent microdialysis catheters that were identical in membrane length, perfusion fluid, and flow rate showed equivalent results. Variations in perfusion fluid and freezing and thawing of samples did not result in differences in substance concentration. Catheter length had a significant impact on substance recovery. Variations in flow rate enabled the relative recovery to be calculated using a modification of the extrapolation-to-zero-flow method. The recovery was approximately 70% at 0.3 µl/minute and 30% at 1 µl/minute (10-mm membrane) for all analytes. Glutamate results obtained with the enzyme analyzer showed good correlation with those from HPLC.

Patients with poor grade aneurysmal subarachnoid haemorrhage (SAH) are associated with high mortality and morbidity, and hence are often treated conservatively. This study has set out to determine the outcome for all poor grade subarachnoid haemorrhage patients, and attempts to identify a subgroup with a more favourable prognosis. During a prospective audit of patients with aneurysmal SAH, patients of poor grade (World Federation of Neurological Surgeons (WFNS) IV (and not obeying commands) and V) were sedated, paralysed and ventilated for transfer to the Regional Neurosurgical Unit. Any intraventricular blood and/or hydrocephalus was treated by external ventricular drainage. Following a 24-h period for active blood gas, fluid and electrolyte resuscitation, patients were assessed after reversal of sedation. Selection for angiography and potential aneurysm surgery was restricted to those who showed a purposeful response to painful stimulation. Patients who could readily obey commands were not considered 'true' poor grade and were excluded from analysis. In 102 patients with 'true' poor grade SAH admitted between 1991 and 1997, the overall management outcome at 6 months was poor (favourable outcome 25%, mortality 67%). Following reversal of sedation, 55 patients demonstrated a purposeful response and proceeded to angiography, of whom 37 underwent clipping and three coiling of aneurysm. The outcome in this aneurysm treated subgroup was favourable in 53% (mortality 28%). If patients over the age of 65 years are excluded, the management outcome was favourable in 35% (mortality 58%), with those patients proceeding to clipping or coiling of aneurysms having a favourable outcome in 57% (mortality 27%). Patients over the age of 65 years with poor grade SAH had a favourable outcome in only 6% (mortality 85%). The mortality for poor grade SAH patients remains high. However, following resuscitation and correction of any acute hydrocephalus, a patient subgroup identified on simple clinical criteria can be identified who can expect a better outcome.

We report the design and clinical application of a new cranial access device (triple bolt) designed to transmit intracranial pressure monitors, multiparameter sensors, microdialysis catheters and laser doppler probes into the cerebral parenchyma. The objective was to achieve insertion on the Neuro-Critical Care Unit, imaging compatibility, angled trajectories and versatility of monitor application. The bolt has been successfully applied to 100 patients with severe head injury and subarachnoid haemorrhage.